• S4 Ep 11: Breaking down the molecular science of cancer with Dr. Craig Horbinski

  • Nov 20 2024
  • Length: 1 hr and 2 mins
  • Podcast

S4 Ep 11: Breaking down the molecular science of cancer with Dr. Craig Horbinski

  • Summary

  • Dr. Horbinski sits down with me to discuss the complexities of brain tumors and how his work in the Feinberg School of Medicine lab is looking into mutIDH1 and how it dramatically alters the glioma’s micro-environmental landscape by preventing the thrombosis-necrosis phenomenon that is characteristic of IDH1 wild-type gliomas. Furthermore, mutIDH1 increases the risk of seizures in patients. He explains why his team's work may improve diagnostic and prognostic accuracy.

    For methylation profiling patient care and information, please send samples to: Northwestern Department of Pathology.

    Season Sponsors:

    GammaTile Therapy

    Imvax Inc.

    Episode Sponsors:

    Highmark BlueCross BlueShield of WNY

    Mimivax Inc.

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about S4 Ep 11: Breaking down the molecular science of cancer with Dr. Craig Horbinski

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.